Sorghum (jowar) is one of the most extensively studied millets for cardiovascular health, distinguished by its unique phytochemical profile that includes 3-deoxyanthocyanidins — flavonoids not found in other cereal grains — with exceptionally potent antioxidant and anti-inflammatory activities. These compounds directly protect cardiac muscle cells from oxidative injury during ischemic events and reduce vascular inflammation that drives atherosclerosis. Sorghum also provides phytosterols that lower LDL cholesterol, magnesium that reduces cardiac arrhythmia risk, and dietary fiber that reduces bile acid recirculation, forcing hepatic cholesterol catabolism. A 16-week clinical study referenced in MDPI Separations (2023) found that sorghum-consuming groups showed significant improvements in all major cardiovascular risk markers.

Key Points

3-Deoxyanthocyanidins in sorghum are unique anti-inflammatory flavonoids that protect cardiac tissue from ischemic oxidative damage

Phytosterols reduce LDL cholesterol absorption by 10–15%, directly reducing cardiovascular plaque burden

Magnesium (165 mg/100g) reduces cardiac arrhythmia risk by stabilizing myocardial electrical conduction pathways

Dietary fiber reduces bile acid recirculation, stimulating hepatic LDL catabolism and reducing circulating cholesterol

Sorghum's low GI (45–50) prevents hyperinsulinemia — a cardiovascular risk factor that promotes arterial inflammation

Evidence Base

MDPI Separations (2023) and Frontiers in Nutrition (2021) landmark reviews classify sorghum as the single most cardioprotective millet variety, with comprehensive evidence across antioxidant, antihypertensive, and hypolipidemic mechanisms.